Acquired C1 inhibitor deficiency associated with lymphoproliferative disorders: Four cases;Déficit acquis en C1 inhibiteur associé à un syndrome lymphoprolifératif: Quatre observations

Revue de Medecine Interne

Volumn 25, Issue 9, 2004, Pages 667-672

  Bibi Triki, T ^a   Eclache, V ^a   Frilay, Y ^a   Stirnemann, J ^a   Fremeaux Bacchi V ^b   Fain, O ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Angio d me; Angioedema; C1 inhibitor deficiency; D ficit en C1 inhibiteur; Lymphoma; Lymphome; Lymphoproliferative disorder; Syndrome lymphoprolif ratif

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; CYCLOPHOSPHAMIDE; DANAZOL; DOXORUBICIN; RITUXIMAB; VINCRISTINE;

ACQUIRED C1 INHIBITOR DEFICIENCY; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; TREATMENT OUTCOME;

AGED; ANGIONEUROTIC EDEMA; ANTIBODIES, ANTICARDIOLIPIN; COMPLEMENT C1 INACTIVATOR PROTEINS; CRYOGLOBULINEMIA; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 4444288108     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.06.003     Document Type: Article

References (24)

1. Kaplan A.P. C1 inhibitor deficiency: hereditary and acquired forms J Investig Allergol Clin Immunol 11 4 2001 211 219
2. Agostoni A., and Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients Medicine (Baltimore) 71 4 1992 206 215
3. Alsenz J., Lambris J.D., Bork K., and Loos M. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies J Clin Invest 83 6 1989 1794 1799
4. Cicardi M., Zingale L.C., Pappalardo E., Folcioni A., and Agostoni A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies Medicine (Baltimore) 82 4 2003 274 281
5. Fremeaux-Bacchi V., Guinnepain M.T., Cacoub P., Dragon-Durey M.A., Mouthon L., and Blouin J. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2 Am J Med 113 3 2002 194 199
6. Phanish M.K., Owen A., and Parry D.H. Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema J Clin Pathol 55 10 2002 789 790
7. Alonso J.M., and Fas M.J. Malignant bladder tumor transurethral resection in a patient with acquired C1 inhibitor deficiency Acta Anaesthesiol Scand 46 6 2002 740 743
8. Wasserfallen J.B., Spaeth P., Guillou L., and Pecoud A.R. Acquired deficiency in C1-inhibitor associated with signet ring cell gastric adenocarcinoma: a probable connection of antitumor-associated antibodies, hemolytic anemia, and complement turnover J Allergy Clin Immunol 95 1 Pt 1 1995 124 131
9. Bain B.J., Catovsky D., and Ewan P.W. Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes Cancer 72 11 1993 3318 3322
10. Bouillet-Claveyrolas L., Ponard D., Drouet C., and Massot C. Clinical and biological distinctions between type I and type II acquired angioedema Am J Med 115 5 2003 420 421
11. D'Incan M., Tridon A., Ponard D., Dumestre-Perard C., Ferrier-Le Bouedec M., and Betail G. Acquired angioedema with C1 inhibitor deficiency: is the distinction between type I and type II still relevant? Dermatology 199 3 1999 227 230
12. Binkley K.E., and Davis A.E. 3rd Estrogen-dependent inherited angioedema Transfus Apheresis Sci 29 3 2003 215 219
13. Andre C., Andre F., Veysseyre-Balter C., and Rousset H. Œdème angioneurotique acquis induit par la contraception hormonale Presse Med 32 18 2003 831 835
14. Bouillet L., Ponard D., Drouet C., Dumestre C., Pernollet M., and Bonerandi J.J. L'œdème angioneurotique acquis. Caracté ristiques cliniques et biologiques chez 9 patients Presse Med 29 12 2000 640 644
15. Bouillet L., Ponard D., Drouet C., and Massot C. L'angio- œdème non allergique : mise au point Rev Med Interne 23 6 2002 533 541
16. Cacoub P., Fremeaux-Bacchi V., De Lacroix I., Guillien F., Kahn M.F., and Kazatchkine M.D. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus Arthritis Rheum 44 8 2001 1836 1840
17. Nagy L., Hannema A., and Swaak A. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus, secondary antiphospholipid syndrome and IgM monoclonal paraproteinaemia Clin Rheumatol 18 1 1999 56 58
18. Kazatchkine M., Hauptmann G., and Nydegger U. Techniques du complément 1985 Inserm Paris
19. Gelfand J.A., Boss G.R., Conley C.L., Reinhart R., and Frank M.M. Acquired C1 esterase inhibitor deficiency and angiooedema Medicine 58 1979 321 328
20. Hory B., Panouse-Perrin J., Dupond J.L., and Leconte des Floris R. Déficit acquis en inhibiteur de la C1 estérase et syndrome lymphoprolifératif Rev Med Interne 6 3 1985 266 271
21. Grosbois B., Goasguen J., and Leblay R. Déficit acquis en inhibiteur de la C1 estérase et syndromes lymphoprolifératifs malins Rev Med Interne 6 4 1985 464
22. Fremeaux-Bacchi V., Weiss L., Demouchy C., Blouin J., and Kazatchkine M.D. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus Lupus 5 3 1996 216 220
23. Hauptmann G., Petitjean F., Lang J.M., and Oberling F. Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy Clin Exp Immunol 37 1979 523 531
24. Richardson S.G., Clarke C.W., and Gasson G.B. Lymphocytic lymphoma and acquired C1 esterase inhibitor deficiency Br J Dermatol 120 1 1989 121 124